BECN1 and neoplasm: In conclusion, the data presented herein show for the first time that, by introducing the Beclin-1 gene into the oncolytic adenoviral backbone, antileukemia activity of the virus can be significantly improved, leading to a complete elimination of leukemia xenografts and prolonged survival of tumor-bearing mice.